(VONG) Russell 1000 Growth Shares - Overview
Etf: Growth, Large-Cap, Stocks, Technology, Healthcare
Dividends
| Dividend Yield | 0.50% |
| Yield on Cost 5y | 0.88% |
| Yield CAGR 5y | -7.82% |
| Payout Consistency | 98.1% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 21.8% |
| Relative Tail Risk | 5.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.40 |
| Alpha | -5.75 |
| Character TTM | |
|---|---|
| Beta | 1.157 |
| Beta Downside | 1.115 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.27% |
| CAGR/Max DD | 1.11 |
Description: VONG Russell 1000 Growth Shares December 17, 2025
The Vanguard Russell 1000 Growth Index Fund ETF (NASDAQ: VONG) seeks to track the performance of large-cap U.S. growth stocks by holding the constituent securities of the Russell 1000 Growth Index in roughly the same weightings. The fund’s replication strategy means it invests nearly all of its assets in the index’s stocks, and its diversification profile can shift if a constituent’s market cap changes enough to alter its index weight.
As of the most recent filing (assumed Q3 2024), VONG carries an expense ratio of 0.08% and manages roughly $2 billion in assets, placing it among the lower-cost, mid-size growth ETFs. Its top ten holdings are heavily weighted toward the technology sector-e.g., Apple, Microsoft, and Amazon-which together account for about 30% of the portfolio. A key macro driver for this ETF is the Federal Reserve’s interest-rate policy; lower rates tend to boost growth-oriented valuations, while rate hikes increase discount-rate pressure on future earnings.
If you want to see a quantitative breakdown of VONG’s risk-adjusted performance and how it aligns with broader growth trends, a quick look at the analytics on ValueRay can be a useful next step.
What is the price of VONG shares?
Over the past week, the price has changed by -2.12%, over one month by -4.02%, over three months by -3.24% and over the past year by +11.14%.
Is VONG a buy, sell or hold?
What are the forecasts/targets for the VONG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 139.7 | 18.9% |
VONG Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 37.67b USD (37.67b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 37.67b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 37.67b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.18% (E(37.67b)/V(37.67b) * Re(10.18%) + (debt-free company))
Discount Rate = 10.18% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)